Clinical Trial

Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis

Study acronym: VD-PD
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2024 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter randomized, placebo-controlled trial of Vitamin D supplementation in patients on peritoneal dialysis to determine whether oral administration of vitamin D3 after curing an episode of peritonitis could reduce the risk of subsequent peritoneal dialysis-related peritonitis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-05-05; most recent amendment 2024-08-05.
Trial Details
NCT Number NCT05860270
Lead Sponsor Peking University First Hospital
Collaborators: Peking University Third Hospital, Peking University People's Hospital, Beijing Haidian Hospital, Peking University Shenzhen Hospital, Beijing Fangshan District Hospital of Traditional Chinese Medicine, Peking University International Hospital, Beijing Tsinghua Changgeng Hospital, Beijing Anzhen Hospital, Capital Medical University
Conditions Peritoneal Dialysis-associated Peritonitis, Vitamin D Deficiency
Enrollment 176 participants
Start Date 2023-06-15
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-06